SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 80 filers reported holding SERES THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is 0.14 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $287,000 | -40.3% | 34,422 | +47.5% | 0.03% | -14.7% |
Q1 2021 | $481,000 | +1133.3% | 23,344 | +108.3% | 0.03% | +750.0% |
Q4 2019 | $39,000 | -17.0% | 11,209 | -23.9% | 0.00% | +33.3% |
Q2 2019 | $47,000 | -39.7% | 14,728 | +38.2% | 0.00% | -25.0% |
Q1 2018 | $78,000 | -68.5% | 10,655 | -31.2% | 0.00% | -66.7% |
Q3 2017 | $248,000 | – | 15,478 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Flagship Pioneering Inc. | 12,682,876 | $125,560,000 | 40.85% |
ARK Investment Management | 492,064 | $4,871,000 | 1.77% |
Artal Group S.A. | 700,000 | $6,930,000 | 0.15% |
Portolan Capital Management | 111,054 | $1,099,000 | 0.15% |
Rock Springs Capital Management LP | 220,000 | $2,178,000 | 0.15% |
CQS Cayman LP | 162,000 | $1,604,000 | 0.13% |
Opus Point Partners Management, LLC | 14,000 | $139,000 | 0.11% |
HAMILTON LANE ADVISORS LLC | 14,883 | $147,000 | 0.10% |
Geduld E E | 15,000 | $149,000 | 0.08% |
Virtus ETF Advisers LLC | 28,148 | $279,000 | 0.08% |